why choose us

First received: November 21, 2022

Clinical Trial: An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Chronic Kidney Disease
Type 2 Diabetes

Study Type: Observational


Official Title: Finerenone on Top of SGLT2is: A coMparatIve Hybrid Study Based oN RCT/RWE Data Of Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

Brief Summary: This is an observational study, in which data from the past of people with chronic kidney disease (CKD) together with type 2 diabetes (T2D) are studied. The participants in this study were treated in the past with a type of drug called SGLT2 inhibitor alone or with SGLT2 inhibitors in combination with finerenone.In observational studies, only observations are made without specified advice or interventions.CKD is a long-term progressive decrease in the kidneys' ability to work properly. In people with T2D, the body…

Read more